TNXB
protein-codingtenascin XB, the group of Tenascins
Gene summary
This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- TNXB1
- TNXB2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~74.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011670
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011670
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011670
Submitter: Illumina
TNXB was first reported in relation to autosomal recessive Ehlers-Danlos syndrome due to tenascin X deficiency in 1997 (9288108: Burch et al. 1997). At least 10 unique variants, both missense and loss of function, have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least seven probands in three publications (26799614: Mackenroth et al. 2015; 27297501: Chen et al. 2016; Demirdas et al. 2017). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is supported by an animal model (11925569: Mao et al. 2002) and rescue experiments (30605228: Aktar et al. 2019). In summary, the TNXB gene is definitively associated with autosomal recessive Ehlers-Danlos syndrome due to tenascin X deficiency.
Inheritance Pattern: AR
Disease ID:MONDO:0011670
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0011670
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014422
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0017329
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0020066
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Dermatologic; Gastrointestinal; Musculoskeletal; Renal
Intervention: Cardiovascular; Gastrointestinal; Renal
Rationale: In Vesicoureteral reflux, monitoring and intervention related to renal sequelae may be beneficial in terms of helping to preserve renal function; In Ehlers-Danlos syndrome, reported features include aortic dilatation (which may not have a high risk of progression), severe diverticular intestinal disease with ruptured diverticula, pancolonic diverticulitis, and rectal prolapse, mitral valve prolapse requiring valve replacement, and obstructive airway disease, though it is not clear if these are all related to TNXB or to other genetic anomalies; Surveillance related to cardiovascular anomalies may be beneficial
Comments: Variants may also be involved in vesicoureteral reflux
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TNXB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001365276.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 23 | 1099 | 17 | 1139 | ||
| missense | 2 | 5 | 1961 | 342 | 3 | 2313 |
| nonsense | 91 | 33 | 2 | 126 | ||
| start loss | 1 | 1 | ||||
| frameshift | 109 | 67 | 5 | 181 | ||
| splice donor/acceptor (+/-2bp) | 21 | 10 | 1 | 32 | ||
| Total | 202 | 126 | 2002 | 1441 | 21 | 3792 |
Highest pathogenic variant AF is 0.00006370509
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001352205.1 | 43 | MANE Select | |
| Ensembl | ENSP00000496448.1 | 43 | MANE Select | |
| RefSeq | NP_001415264.1 | 44 | Standard | |
| RefSeq | NP_061978.6 | 43 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- ECM-receptor interaction - Homo sapiens (human)
- Focal adhesion - Homo sapiens (human)
- MicroRNAs in cancer - Homo sapiens (human)
- Human papillomavirus infection - Homo sapiens (human)
Biological Process
- cell adhesion
- actin cytoskeleton organization
- collagen fibril organization
- collagen metabolic process
- elastic fiber assembly
Molecular Function
- integrin binding
- extracellular matrix structural constituent
- protein binding
- heparin binding
- collagen fibril binding
Cellular Component
- extracellular region
- extracellular space
- extracellular matrix
- collagen-containing extracellular matrix
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000451343
- Coding exons
- 13
- Length
- 74181
- Individuals with no LoFs
- 125689
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125694
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0433 | 245 | 247 | 0.992 | 0.0000160 | 4182 |
| Missense (PolyPhen) | 158 | 166.01 | 0.95173 | 2892 | ||
| Synonymous | 0.804 | 95 | 106 | 0.900 | 0.00000774 | 1359 |
| Loss of Function | 2.94 | 7 | 21.8 | 0.321 | 0.00000110 | 324 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0.000069 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Appears to mediate interactions between cells and the extracellular matrix. Substrate-adhesion molecule that appears to inhibit cell migration. Accelerates collagen fibril formation. May play a role in supporting the growth of epithelial tumors. {ECO:0000269|PubMed:17033827}.;
- Disease
- DISEASE: Ehlers-Danlos syndrome, classic-like (EDSCLL) [MIM:606408]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSCLL patients lack atrophic scars, a major diagnostic criteria for classic Ehlers-Danlos syndrome. Delayed wound healing is only present in a subset of patients. EDSCLL inheritance is autosomal recessive. {ECO:0000269|PubMed:11642233, ECO:0000269|PubMed:15733269, ECO:0000269|PubMed:23768946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vesicoureteral reflux 8 (VUR8) [MIM:615963]: A disease belonging to the group of congenital anomalies of the kidney and urinary tract. It is characterized by the reflux of urine from the bladder into the ureters and sometimes into the kidneys, and is a risk factor for urinary tract infections. Primary disease results from a developmental defect of the ureterovesical junction. In combination with intrarenal reflux, the resulting inflammatory reaction may result in renal injury or scarring, also called reflux nephropathy. Extensive renal scarring impairs renal function and may predispose patients to hypertension, proteinuria, renal insufficiency and end-stage renal disease. {ECO:0000269|PubMed:23620400}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.161
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |